Furthermore, T cells from mice vaccinated with CD47KO B16F0 cells showed an increased IFN-γ production (Fig. 1d) and enhanced killing of tumor target cells (Supplementary Fig. 2a) compared to those from mice receiving medium or WT B16F0 cell vaccination. This evidence concerns the gene IFNG and neoplasm.